| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 2.65e-06 | 2 | 33 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 5.53e-05 | 7 | 33 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 9.47e-05 | 9 | 33 | 2 | GO:0004690 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 1.18e-04 | 10 | 33 | 2 | GO:0004679 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 3.02e-04 | 363 | 33 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 5.99e-04 | 22 | 33 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 7.70e-04 | 446 | 33 | 5 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 9.75e-04 | 28 | 33 | 2 | GO:0008320 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 1.44e-03 | 34 | 33 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 1.44e-03 | 34 | 33 | 2 | GO:0008266 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.51e-03 | 775 | 33 | 6 | GO:0016746 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 1.89e-03 | 39 | 33 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | protein transporter activity | 2.19e-03 | 42 | 33 | 2 | GO:0140318 | |
| GeneOntologyMolecularFunction | tau protein binding | 2.62e-03 | 46 | 33 | 2 | GO:0048156 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.85e-03 | 600 | 33 | 5 | GO:0004672 | |
| GeneOntologyMolecularFunction | signal sequence binding | 3.21e-03 | 51 | 33 | 2 | GO:0005048 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 3.34e-03 | 52 | 33 | 2 | GO:0035255 | |
| GeneOntologyBiologicalProcess | regulation of bicellular tight junction assembly | 9.82e-06 | 28 | 31 | 3 | GO:2000810 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 1.31e-05 | 4 | 31 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | negative regulation of bicellular tight junction assembly | 4.57e-05 | 7 | 31 | 2 | GO:1903347 | |
| GeneOntologyBiologicalProcess | protein kinase A signaling | 5.08e-05 | 48 | 31 | 3 | GO:0010737 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane, translocation | 6.09e-05 | 8 | 31 | 2 | GO:0006616 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to membrane, translocation | 6.09e-05 | 8 | 31 | 2 | GO:0031204 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 9.10e-05 | 159 | 31 | 4 | GO:0001838 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 1.10e-04 | 167 | 31 | 4 | GO:0007043 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 1.26e-04 | 173 | 31 | 4 | GO:0072175 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.38e-04 | 67 | 31 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | positive regulation of connective tissue replacement | 1.69e-04 | 13 | 31 | 2 | GO:1905205 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 1.69e-04 | 13 | 31 | 2 | GO:0034380 | |
| GeneOntologyBiologicalProcess | tube formation | 1.70e-04 | 187 | 31 | 4 | GO:0035148 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 1.81e-04 | 190 | 31 | 4 | GO:0016331 | |
| GeneOntologyBiologicalProcess | mitochondrion organization | 2.12e-04 | 589 | 31 | 6 | GO:0007005 | |
| GeneOntologyBiologicalProcess | bicellular tight junction assembly | 2.42e-04 | 81 | 31 | 3 | GO:0070830 | |
| GeneOntologyBiologicalProcess | tight junction assembly | 3.09e-04 | 88 | 31 | 3 | GO:0120192 | |
| GeneOntologyBiologicalProcess | regulation of connective tissue replacement | 3.29e-04 | 18 | 31 | 2 | GO:1905203 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 3.31e-04 | 90 | 31 | 3 | GO:0043297 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast proliferation | 3.68e-04 | 19 | 31 | 2 | GO:2000288 | |
| GeneOntologyBiologicalProcess | tight junction organization | 3.76e-04 | 94 | 31 | 3 | GO:0120193 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 4.08e-04 | 20 | 31 | 2 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 4.08e-04 | 20 | 31 | 2 | GO:1903140 | |
| GeneOntologyBiologicalProcess | post-translational protein targeting to endoplasmic reticulum membrane | 4.51e-04 | 21 | 31 | 2 | GO:0006620 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 4.82e-04 | 246 | 31 | 4 | GO:0045216 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 5.87e-04 | 713 | 31 | 6 | GO:0048598 | |
| GeneOntologyBiologicalProcess | negative regulation of meiotic cell cycle | 5.91e-04 | 24 | 31 | 2 | GO:0051447 | |
| GeneOntologyBiologicalProcess | angiotensin-activated signaling pathway | 5.91e-04 | 24 | 31 | 2 | GO:0038166 | |
| GeneOntologyBiologicalProcess | positive regulation of tissue remodeling | 5.91e-04 | 24 | 31 | 2 | GO:0034105 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 6.11e-04 | 262 | 31 | 4 | GO:0048771 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 6.42e-04 | 25 | 31 | 2 | GO:2000114 | |
| GeneOntologyBiologicalProcess | neural tube closure | 6.44e-04 | 113 | 31 | 3 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 6.60e-04 | 114 | 31 | 3 | GO:0060606 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 6.77e-04 | 115 | 31 | 3 | GO:0018107 | |
| GeneOntologyBiologicalProcess | connective tissue replacement | 6.95e-04 | 26 | 31 | 2 | GO:0097709 | |
| GeneOntologyBiologicalProcess | renal water homeostasis | 6.95e-04 | 26 | 31 | 2 | GO:0003091 | |
| GeneOntologyBiologicalProcess | SRP-dependent cotranslational protein targeting to membrane | 7.50e-04 | 27 | 31 | 2 | GO:0006614 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 7.66e-04 | 120 | 31 | 3 | GO:0014020 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 8.26e-04 | 284 | 31 | 4 | GO:0009913 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 8.63e-04 | 125 | 31 | 3 | GO:0018210 | |
| GeneOntologyBiologicalProcess | mitochondrial DNA metabolic process | 8.65e-04 | 29 | 31 | 2 | GO:0032042 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle assembly | 8.65e-04 | 29 | 31 | 2 | GO:0034377 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 8.97e-04 | 509 | 31 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 9.21e-04 | 512 | 31 | 5 | GO:0031400 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 9.24e-04 | 128 | 31 | 3 | GO:0034103 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphatase activity | 9.26e-04 | 30 | 31 | 2 | GO:0010923 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 9.26e-04 | 30 | 31 | 2 | GO:0032878 | |
| GeneOntologyBiologicalProcess | intracellular protein transmembrane transport | 9.89e-04 | 31 | 31 | 2 | GO:0065002 | |
| GeneOntologyBiologicalProcess | regulation of synapse maturation | 9.89e-04 | 31 | 31 | 2 | GO:0090128 | |
| GeneOntologyBiologicalProcess | embryo development | 1.01e-03 | 1437 | 31 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | cotranslational protein targeting to membrane | 1.05e-03 | 32 | 31 | 2 | GO:0006613 | |
| GeneOntologyBiologicalProcess | negative regulation of biomineral tissue development | 1.05e-03 | 32 | 31 | 2 | GO:0070168 | |
| GeneOntologyBiologicalProcess | regulation of myoblast proliferation | 1.05e-03 | 32 | 31 | 2 | GO:2000291 | |
| GeneOntologyBiologicalProcess | neural tube formation | 1.05e-03 | 134 | 31 | 3 | GO:0001841 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.10e-03 | 307 | 31 | 4 | GO:0018105 | |
| GeneOntologyBiologicalProcess | protein-lipid complex assembly | 1.12e-03 | 33 | 31 | 2 | GO:0065005 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.13e-03 | 309 | 31 | 4 | GO:1901888 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level water homeostasis | 1.26e-03 | 35 | 31 | 2 | GO:0050891 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.27e-03 | 319 | 31 | 4 | GO:0018209 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 1.56e-03 | 39 | 31 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 1.57e-03 | 154 | 31 | 3 | GO:0090090 | |
| GeneOntologyBiologicalProcess | cellular response to angiotensin | 1.65e-03 | 40 | 31 | 2 | GO:1904385 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte differentiation | 1.65e-03 | 40 | 31 | 2 | GO:0045616 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 1.69e-03 | 158 | 31 | 3 | GO:0045446 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 1.73e-03 | 41 | 31 | 2 | GO:1901889 | |
| GeneOntologyBiologicalProcess | mitochondrial genome maintenance | 1.81e-03 | 42 | 31 | 2 | GO:0000002 | |
| GeneOntologyBiologicalProcess | negative regulation of smoothened signaling pathway | 1.81e-03 | 42 | 31 | 2 | GO:0045879 | |
| GeneOntologyBiologicalProcess | myoblast proliferation | 1.90e-03 | 43 | 31 | 2 | GO:0051450 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.96e-03 | 359 | 31 | 4 | GO:0006874 | |
| GeneOntologyBiologicalProcess | negative regulation of dephosphorylation | 1.99e-03 | 44 | 31 | 2 | GO:0035305 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 2.03e-03 | 906 | 31 | 6 | GO:0043009 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 2.08e-03 | 45 | 31 | 2 | GO:0030866 | |
| GeneOntologyBiologicalProcess | aortic valve development | 2.17e-03 | 46 | 31 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 2.21e-03 | 1256 | 31 | 7 | GO:0051726 | |
| GeneOntologyBiologicalProcess | skin development | 2.25e-03 | 373 | 31 | 4 | GO:0043588 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 2.27e-03 | 175 | 31 | 3 | GO:0016525 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 2.30e-03 | 929 | 31 | 6 | GO:0009792 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 2.38e-03 | 178 | 31 | 3 | GO:2000181 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 2.43e-03 | 381 | 31 | 4 | GO:0071375 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 2.45e-03 | 180 | 31 | 3 | GO:1901343 | |
| GeneOntologyBiologicalProcess | endothelium development | 2.53e-03 | 182 | 31 | 3 | GO:0003158 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta formation | 2.56e-03 | 50 | 31 | 2 | GO:1902003 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 2.56e-03 | 50 | 31 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | synapse maturation | 2.56e-03 | 50 | 31 | 2 | GO:0060074 | |
| GeneOntologyBiologicalProcess | response to angiotensin | 2.56e-03 | 50 | 31 | 2 | GO:1990776 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 2.57e-03 | 387 | 31 | 4 | GO:0050807 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.62e-03 | 389 | 31 | 4 | GO:0055074 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.69e-03 | 392 | 31 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | negative regulation of TORC1 signaling | 2.77e-03 | 52 | 31 | 2 | GO:1904262 | |
| GeneOntologyBiologicalProcess | protein targeting to ER | 2.77e-03 | 52 | 31 | 2 | GO:0045047 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 2.77e-03 | 395 | 31 | 4 | GO:0050803 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.82e-03 | 189 | 31 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 2.95e-03 | 192 | 31 | 3 | GO:0045667 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle hypertrophy | 2.98e-03 | 54 | 31 | 2 | GO:0010613 | |
| GeneOntologyCellularComponent | Sec61 translocon complex | 2.56e-05 | 5 | 34 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | translocon complex | 3.84e-05 | 6 | 34 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 1.15e-04 | 10 | 34 | 2 | GO:0005952 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum membrane | 1.01e-03 | 29 | 34 | 2 | GO:0030867 | |
| GeneOntologyCellularComponent | mitochondrial matrix | 1.47e-03 | 523 | 34 | 5 | GO:0005759 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.54e-03 | 141 | 34 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 2.02e-03 | 155 | 34 | 3 | GO:0098685 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.88e-03 | 49 | 34 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | mitochondrial nucleoid | 3.11e-03 | 51 | 34 | 2 | GO:0042645 | |
| GeneOntologyCellularComponent | nucleoid | 3.11e-03 | 51 | 34 | 2 | GO:0009295 | |
| GeneOntologyCellularComponent | microtubule organizing center | 3.32e-03 | 919 | 34 | 6 | GO:0005815 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 3.60e-03 | 934 | 34 | 6 | GO:0048471 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 3.74e-03 | 56 | 34 | 2 | GO:0099091 | |
| GeneOntologyCellularComponent | ciliary base | 3.74e-03 | 56 | 34 | 2 | GO:0097546 | |
| GeneOntologyCellularComponent | spindle pole | 4.45e-03 | 205 | 34 | 3 | GO:0000922 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum | 4.86e-03 | 64 | 34 | 2 | GO:0005791 | |
| MousePheno | abnormal proximal-distal axis patterning | 2.26e-06 | 13 | 29 | 3 | MP:0001705 | |
| MousePheno | ocular hypotension | 4.14e-05 | 5 | 29 | 2 | MP:0005260 | |
| MousePheno | absent ectoplacental cone | 1.48e-04 | 9 | 29 | 2 | MP:0001717 | |
| MousePheno | increased hepatocyte apoptosis | 1.56e-04 | 51 | 29 | 3 | MP:0003887 | |
| MousePheno | reduced long-term potentiation | 1.94e-04 | 141 | 29 | 4 | MP:0001473 | |
| MousePheno | abnormal ectoderm development | 1.96e-04 | 55 | 29 | 3 | MP:0001675 | |
| MousePheno | abnormal operant conditioning behavior | 3.20e-04 | 13 | 29 | 2 | MP:0002803 | |
| MousePheno | hemorrhage | 3.30e-04 | 664 | 29 | 7 | MP:0001914 | |
| MousePheno | absent extraembryonic ectoderm | 4.29e-04 | 15 | 29 | 2 | MP:0002583 | |
| MousePheno | small embryonic epiblast | 4.29e-04 | 15 | 29 | 2 | MP:0011189 | |
| Domain | AGC-kinase_C | 5.26e-08 | 56 | 34 | 5 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 5.26e-08 | 56 | 34 | 5 | PS51285 | |
| Domain | S_TK_X | 5.26e-08 | 56 | 34 | 5 | SM00133 | |
| Domain | Pkinase_C | 9.75e-07 | 42 | 34 | 4 | PF00433 | |
| Domain | Rho_Binding | 3.22e-06 | 2 | 34 | 2 | PF08912 | |
| Domain | Plug_translocon | 3.22e-06 | 2 | 34 | 2 | PF10559 | |
| Domain | SecY_su_dom | 3.22e-06 | 2 | 34 | 2 | IPR023201 | |
| Domain | SecY_CS | 3.22e-06 | 2 | 34 | 2 | IPR030659 | |
| Domain | Rho-bd_dom | 3.22e-06 | 2 | 34 | 2 | IPR015008 | |
| Domain | SecY | 3.22e-06 | 2 | 34 | 2 | PF00344 | |
| Domain | ROCK1/ROCK2 | 3.22e-06 | 2 | 34 | 2 | IPR020684 | |
| Domain | SECY_1 | 3.22e-06 | 2 | 34 | 2 | PS00755 | |
| Domain | SECY_2 | 3.22e-06 | 2 | 34 | 2 | PS00756 | |
| Domain | SecY/SEC61-alpha | 3.22e-06 | 2 | 34 | 2 | IPR002208 | |
| Domain | - | 3.22e-06 | 2 | 34 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 3.22e-06 | 2 | 34 | 2 | IPR019561 | |
| Domain | DUF3523 | 9.64e-06 | 3 | 34 | 2 | PF12037 | |
| Domain | DUF3523 | 9.64e-06 | 3 | 34 | 2 | IPR021911 | |
| Domain | Pkinase_C | 4.11e-05 | 37 | 34 | 3 | IPR017892 | |
| Domain | HR1 | 8.95e-05 | 8 | 34 | 2 | PF02185 | |
| Domain | Ser/Thr_kinase_AS | 4.38e-04 | 357 | 34 | 5 | IPR008271 | |
| Domain | S_TKc | 4.49e-04 | 359 | 34 | 5 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 4.66e-04 | 362 | 34 | 5 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 5.74e-04 | 379 | 34 | 5 | IPR017441 | |
| Domain | Pkinase | 5.88e-04 | 381 | 34 | 5 | PF00069 | |
| Domain | RCC1 | 5.99e-04 | 20 | 34 | 2 | PF00415 | |
| Domain | RCC1_3 | 6.61e-04 | 21 | 34 | 2 | PS50012 | |
| Domain | RCC1_1 | 6.61e-04 | 21 | 34 | 2 | PS00625 | |
| Domain | RCC1_2 | 6.61e-04 | 21 | 34 | 2 | PS00626 | |
| Domain | Reg_chr_condens | 7.26e-04 | 22 | 34 | 2 | IPR000408 | |
| Domain | - | 7.26e-04 | 22 | 34 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 7.95e-04 | 23 | 34 | 2 | IPR009091 | |
| Domain | HECT | 1.10e-03 | 27 | 34 | 2 | PF00632 | |
| Domain | HECTc | 1.10e-03 | 27 | 34 | 2 | SM00119 | |
| Domain | HECT_dom | 1.10e-03 | 27 | 34 | 2 | IPR000569 | |
| Domain | HECT | 1.10e-03 | 27 | 34 | 2 | PS50237 | |
| Domain | PROTEIN_KINASE_ATP | 1.36e-03 | 459 | 34 | 5 | PS00107 | |
| Domain | Prot_kinase_dom | 1.79e-03 | 489 | 34 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.86e-03 | 493 | 34 | 5 | PS50011 | |
| Domain | Kinase-like_dom | 2.80e-03 | 542 | 34 | 5 | IPR011009 | |
| Domain | AAA | 4.03e-03 | 52 | 34 | 2 | PF00004 | |
| Domain | ATPase_AAA_core | 4.34e-03 | 54 | 34 | 2 | IPR003959 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.62e-06 | 103 | 28 | 5 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.87e-06 | 106 | 28 | 5 | M27077 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 1.98e-06 | 13 | 28 | 3 | M47547 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 3.68e-06 | 54 | 28 | 4 | M17906 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.06e-05 | 151 | 28 | 5 | M19428 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 3.79e-05 | 5 | 28 | 2 | M49031 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 3.79e-05 | 5 | 28 | 2 | M26988 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 3.79e-05 | 5 | 28 | 2 | MM15221 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 3.96e-05 | 98 | 28 | 4 | M39830 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 4.40e-05 | 35 | 28 | 3 | M41738 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 5.21e-05 | 37 | 28 | 3 | MM15683 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 5.68e-05 | 6 | 28 | 2 | MM14628 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 7.40e-05 | 115 | 28 | 4 | M9387 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 7.65e-05 | 42 | 28 | 3 | M27308 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 7.94e-05 | 7 | 28 | 2 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 7.94e-05 | 7 | 28 | 2 | MM15560 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 9.02e-05 | 121 | 28 | 4 | M39823 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 1.06e-04 | 8 | 28 | 2 | M27840 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 1.36e-04 | 9 | 28 | 2 | M27877 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY | 1.36e-04 | 9 | 28 | 2 | M47546 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 1.70e-04 | 10 | 28 | 2 | M47648 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.72e-04 | 55 | 28 | 3 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.81e-04 | 56 | 28 | 3 | M2333 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.07e-04 | 11 | 28 | 2 | MM15046 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 2.07e-04 | 11 | 28 | 2 | M47721 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 2.48e-04 | 12 | 28 | 2 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 2.48e-04 | 12 | 28 | 2 | M27363 | |
| Pathway | WP_DOPAMINE_METABOLISM | 2.93e-04 | 13 | 28 | 2 | M39622 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 2.93e-04 | 13 | 28 | 2 | M47731 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 3.37e-04 | 69 | 28 | 3 | M237 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 3.51e-04 | 70 | 28 | 3 | M3115 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 3.93e-04 | 15 | 28 | 2 | MM15019 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 3.93e-04 | 15 | 28 | 2 | MM15037 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 3.93e-04 | 15 | 28 | 2 | M47794 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 3.93e-04 | 15 | 28 | 2 | MM15103 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 3.93e-04 | 15 | 28 | 2 | M138 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 3.93e-04 | 15 | 28 | 2 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M47645 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 4.49e-04 | 16 | 28 | 2 | MM14699 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.49e-04 | 16 | 28 | 2 | MM14492 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 4.49e-04 | 16 | 28 | 2 | M923 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 4.49e-04 | 16 | 28 | 2 | M40060 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 4.50e-04 | 184 | 28 | 4 | MM15943 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 4.88e-04 | 188 | 28 | 4 | M4844 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 5.08e-04 | 17 | 28 | 2 | MM15561 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 5.08e-04 | 17 | 28 | 2 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 5.08e-04 | 17 | 28 | 2 | M47544 | |
| Pathway | WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION | 5.08e-04 | 17 | 28 | 2 | M39907 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 5.08e-04 | 17 | 28 | 2 | MM15215 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.20e-04 | 532 | 28 | 6 | M27870 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 6.37e-04 | 19 | 28 | 2 | M27841 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 6.37e-04 | 19 | 28 | 2 | M27493 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 7.07e-04 | 20 | 28 | 2 | M18415 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 7.07e-04 | 20 | 28 | 2 | MM1445 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 7.07e-04 | 20 | 28 | 2 | M759 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 7.58e-04 | 91 | 28 | 3 | M39700 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 7.81e-04 | 21 | 28 | 2 | M11650 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 7.81e-04 | 21 | 28 | 2 | M27485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 7.81e-04 | 21 | 28 | 2 | M47767 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 7.83e-04 | 92 | 28 | 3 | M27201 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.84e-04 | 575 | 28 | 6 | M29853 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 8.27e-04 | 381 | 28 | 5 | M1066 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 8.34e-04 | 94 | 28 | 3 | M2843 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 9.38e-04 | 828 | 28 | 7 | M1058 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 9.38e-04 | 23 | 28 | 2 | M41817 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 9.69e-04 | 99 | 28 | 3 | MM15905 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 1.02e-03 | 24 | 28 | 2 | M10064 | |
| Pathway | KEGG_PROTEIN_EXPORT | 1.02e-03 | 24 | 28 | 2 | M6981 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.02e-03 | 24 | 28 | 2 | M2243 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.02e-03 | 24 | 28 | 2 | M47520 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 1.02e-03 | 24 | 28 | 2 | M751 | |
| Pathway | KEGG_MELANOGENESIS | 1.03e-03 | 101 | 28 | 3 | M7761 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.11e-03 | 25 | 28 | 2 | MM15608 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.12e-03 | 104 | 28 | 3 | M39625 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.20e-03 | 26 | 28 | 2 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.20e-03 | 26 | 28 | 2 | MM14495 | |
| Pathway | PID_IL3_PATHWAY | 1.20e-03 | 26 | 28 | 2 | M182 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.25e-03 | 418 | 28 | 5 | MM15587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.29e-03 | 27 | 28 | 2 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.29e-03 | 27 | 28 | 2 | M47519 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.29e-03 | 27 | 28 | 2 | MM15664 | |
| Pathway | WP_1P36_COPY_NUMBER_VARIATION_SYNDROME | 1.38e-03 | 112 | 28 | 3 | M48072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.39e-03 | 28 | 28 | 2 | M47647 | |
| Pathway | WP_GASTRIN_SIGNALING | 1.49e-03 | 115 | 28 | 3 | M39866 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.49e-03 | 29 | 28 | 2 | M27309 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.49e-03 | 29 | 28 | 2 | M39762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 1.49e-03 | 29 | 28 | 2 | M47627 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.49e-03 | 29 | 28 | 2 | M39676 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.49e-03 | 29 | 28 | 2 | M47515 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 1.53e-03 | 116 | 28 | 3 | M2164 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.60e-03 | 30 | 28 | 2 | M42578 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.66e-03 | 261 | 28 | 4 | MM15676 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.71e-03 | 31 | 28 | 2 | MM15094 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.71e-03 | 31 | 28 | 2 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.82e-03 | 32 | 28 | 2 | M47506 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.82e-03 | 32 | 28 | 2 | MM14983 | |
| Pathway | WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN | 1.93e-03 | 33 | 28 | 2 | M48071 | |
| Pathway | PID_NCADHERIN_PATHWAY | 1.93e-03 | 33 | 28 | 2 | M266 | |
| Pubmed | 1.70e-08 | 6 | 34 | 3 | 26040287 | ||
| Pubmed | Shroom regulates epithelial cell shape via the apical positioning of an actomyosin network. | 1.70e-08 | 6 | 34 | 3 | 16249236 | |
| Pubmed | Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. | 4.76e-08 | 8 | 34 | 3 | 15797222 | |
| Pubmed | TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | 1.02e-07 | 117 | 34 | 5 | 36898370 | |
| Pubmed | 1.02e-07 | 10 | 34 | 3 | 23723064 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35523828 | ||
| Pubmed | Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1. | 9.28e-07 | 2 | 34 | 2 | 31603583 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29115372 | ||
| Pubmed | Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma. | 9.28e-07 | 2 | 34 | 2 | 24617500 | |
| Pubmed | [Ouabain induces Rho-dependent rock activation and membrane blebbing incultured endothelial cells]. | 9.28e-07 | 2 | 34 | 2 | 25916120 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18480044 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 32245259 | ||
| Pubmed | Expression of RNA-binding protein Musashi in hair follicle development and hair cycle progression. | 9.28e-07 | 2 | 34 | 2 | 16400011 | |
| Pubmed | Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells. | 9.28e-07 | 2 | 34 | 2 | 23479079 | |
| Pubmed | Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. | 9.28e-07 | 2 | 34 | 2 | 19590140 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24429217 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12778124 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18495812 | ||
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 9.28e-07 | 2 | 34 | 2 | 3023318 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26468018 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28035042 | ||
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 9.28e-07 | 2 | 34 | 2 | 22462535 | |
| Pubmed | Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction. | 9.28e-07 | 2 | 34 | 2 | 30165352 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 32877952 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30196430 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29800294 | ||
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 9.28e-07 | 2 | 34 | 2 | 19965870 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18668558 | ||
| Pubmed | Role of Rho-kinase in regulation of insulin action and glucose homeostasis. | 9.28e-07 | 2 | 34 | 2 | 16098829 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28709411 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 32234882 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15096457 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 21471517 | ||
| Pubmed | Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. | 9.28e-07 | 2 | 34 | 2 | 25840982 | |
| Pubmed | ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. | 9.28e-07 | 2 | 34 | 2 | 22934846 | |
| Pubmed | ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. | 9.28e-07 | 2 | 34 | 2 | 16098146 | |
| Pubmed | Functional role of Rho-kinase in ameloblast differentiation. | 9.28e-07 | 2 | 34 | 2 | 21792909 | |
| Pubmed | Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. | 9.28e-07 | 2 | 34 | 2 | 20803696 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12180908 | ||
| Pubmed | The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice. | 9.28e-07 | 2 | 34 | 2 | 33168629 | |
| Pubmed | Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. | 9.28e-07 | 2 | 34 | 2 | 26481340 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18331468 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29211497 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30369081 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29987023 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 8772201 | ||
| Pubmed | Msi RNA-binding proteins control reserve intestinal stem cell quiescence. | 9.28e-07 | 2 | 34 | 2 | 27799368 | |
| Pubmed | ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. | 9.28e-07 | 2 | 34 | 2 | 19131646 | |
| Pubmed | Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors. | 9.28e-07 | 2 | 34 | 2 | 31302146 | |
| Pubmed | Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. | 9.28e-07 | 2 | 34 | 2 | 23328676 | |
| Pubmed | The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. | 9.28e-07 | 2 | 34 | 2 | 18695890 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20169147 | ||
| Pubmed | The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity. | 9.28e-07 | 2 | 34 | 2 | 16717192 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24170433 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12508221 | ||
| Pubmed | ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. | 9.28e-07 | 2 | 34 | 2 | 30884801 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 18695640 | ||
| Pubmed | Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state. | 9.28e-07 | 2 | 34 | 2 | 25380226 | |
| Pubmed | Rho-associated kinases play a role in endocardial cell differentiation and migration. | 9.28e-07 | 2 | 34 | 2 | 15464581 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31678302 | ||
| Pubmed | Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus. | 9.28e-07 | 2 | 34 | 2 | 23789633 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28225294 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15044207 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28744352 | ||
| Pubmed | ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. | 9.28e-07 | 2 | 34 | 2 | 18414683 | |
| Pubmed | ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice. | 9.28e-07 | 2 | 34 | 2 | 31914704 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 22113197 | ||
| Pubmed | Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. | 9.28e-07 | 2 | 34 | 2 | 22348083 | |
| Pubmed | Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets. | 9.28e-07 | 2 | 34 | 2 | 28143872 | |
| Pubmed | Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein. | 9.28e-07 | 2 | 34 | 2 | 35840700 | |
| Pubmed | Systems-level identification of PKA-dependent signaling in epithelial cells. | 9.28e-07 | 2 | 34 | 2 | 28973931 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 30771534 | ||
| Pubmed | Rho-associated kinase is a therapeutic target in neuroblastoma. | 9.28e-07 | 2 | 34 | 2 | 28739902 | |
| Pubmed | Matrix rigidity differentially regulates invadopodia activity through ROCK1 and ROCK2. | 9.28e-07 | 2 | 34 | 2 | 26826790 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24562870 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 36152045 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 38841868 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 25934709 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29246448 | ||
| Pubmed | ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. | 9.28e-07 | 2 | 34 | 2 | 26276827 | |
| Pubmed | Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. | 9.28e-07 | 2 | 34 | 2 | 28679962 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 27791202 | ||
| Pubmed | ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease. | 9.28e-07 | 2 | 34 | 2 | 38199985 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 37481823 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17167780 | ||
| Pubmed | ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders. | 9.28e-07 | 2 | 34 | 2 | 27033194 | |
| Pubmed | Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates. | 9.28e-07 | 2 | 34 | 2 | 27269648 | |
| Pubmed | Overexpression of ROCK1 and ROCK2 inhibits human laryngeal squamous cell carcinoma. | 9.28e-07 | 2 | 34 | 2 | 25755711 | |
| Pubmed | Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase. | 9.28e-07 | 2 | 34 | 2 | 24289040 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 26131972 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12407178 | ||
| Pubmed | Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma. | 9.28e-07 | 2 | 34 | 2 | 33278350 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 37871652 | ||
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. | 9.28e-07 | 2 | 34 | 2 | 23392171 | |
| Pubmed | RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family. | 9.28e-07 | 2 | 34 | 2 | 25851660 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 23250919 | ||
| Pubmed | Assessment of MUSASHI 1 and MUSASHI 2 expression in spermatozoa and testicular tissue. | 9.28e-07 | 2 | 34 | 2 | 34309875 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 28923399 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 17347801 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 24168723 | ||
| Interaction | STUB1 interactions | 5.95e-06 | 608 | 34 | 8 | int:STUB1 | |
| Interaction | ATAD3A interactions | 1.68e-05 | 330 | 34 | 6 | int:ATAD3A | |
| Cytoband | 4q22.1 | 1.71e-04 | 26 | 34 | 2 | 4q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 3.46e-04 | 184 | 34 | 3 | chr3p22 | |
| Cytoband | 3p22.1 | 4.08e-04 | 40 | 34 | 2 | 3p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q22 | 1.39e-03 | 74 | 34 | 2 | chr4q22 | |
| Cytoband | 1p36.33 | 1.50e-03 | 77 | 34 | 2 | 1p36.33 | |
| GeneFamily | AAA ATPases | 2.05e-03 | 53 | 23 | 2 | 413 | |
| GeneFamily | RNA binding motif containing | 2.40e-03 | 213 | 23 | 3 | 725 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.79e-02 | 206 | 23 | 2 | 682 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 183 | 34 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Chrna6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-04 | 125 | 34 | 3 | fac8a9bff83abb8976013ff7d2b4ce0b68fbb70a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-04 | 130 | 34 | 3 | c63f402d6ab71c2fcef12174b3139e55a727266c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-04 | 156 | 34 | 3 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 162 | 34 | 3 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 162 | 34 | 3 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.57e-04 | 163 | 34 | 3 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.57e-04 | 163 | 34 | 3 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|COVID-19_Severe / Disease condition and Cell class | 2.71e-04 | 166 | 34 | 3 | 0f138dbafad6f83975944e8f6398411127b150cc | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 2.81e-04 | 168 | 34 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-04 | 170 | 34 | 3 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 2.96e-04 | 171 | 34 | 3 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 172 | 34 | 3 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 173 | 34 | 3 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 174 | 34 | 3 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.17e-04 | 175 | 34 | 3 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 176 | 34 | 3 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-04 | 177 | 34 | 3 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 3.33e-04 | 178 | 34 | 3 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | critical-Lymphoid-NK|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.44e-04 | 180 | 34 | 3 | 5abf778395392244daaec876f306ed7e4f388686 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.50e-04 | 181 | 34 | 3 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.61e-04 | 183 | 34 | 3 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 3.67e-04 | 184 | 34 | 3 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 3.73e-04 | 185 | 34 | 3 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-04 | 185 | 34 | 3 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.73e-04 | 185 | 34 | 3 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.79e-04 | 186 | 34 | 3 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-04 | 187 | 34 | 3 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.91e-04 | 188 | 34 | 3 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 4.03e-04 | 190 | 34 | 3 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 190 | 34 | 3 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 4.03e-04 | 190 | 34 | 3 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 191 | 34 | 3 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.09e-04 | 191 | 34 | 3 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.09e-04 | 191 | 34 | 3 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-04 | 191 | 34 | 3 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-04 | 191 | 34 | 3 | 054fa0493b00149313c243d39cf39a264044f074 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.09e-04 | 191 | 34 | 3 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-04 | 191 | 34 | 3 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 192 | 34 | 3 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 192 | 34 | 3 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.15e-04 | 192 | 34 | 3 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 192 | 34 | 3 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 192 | 34 | 3 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.15e-04 | 192 | 34 | 3 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 4.22e-04 | 193 | 34 | 3 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-04 | 193 | 34 | 3 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.22e-04 | 193 | 34 | 3 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 4.22e-04 | 193 | 34 | 3 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 193 | 34 | 3 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-04 | 194 | 34 | 3 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.28e-04 | 194 | 34 | 3 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.28e-04 | 194 | 34 | 3 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.28e-04 | 194 | 34 | 3 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-04 | 194 | 34 | 3 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-04 | 194 | 34 | 3 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.35e-04 | 195 | 34 | 3 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.41e-04 | 196 | 34 | 3 | 6566e6671257f7df4d3f375e84f0b292ab4bcde1 | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.41e-04 | 196 | 34 | 3 | 3408d561d29802fca9eff5c54ccf70818d240cea | |
| ToppCell | Mild|World / Disease group and Cell class | 4.41e-04 | 196 | 34 | 3 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | C_05|World / shred on cell type and cluster | 4.41e-04 | 196 | 34 | 3 | bf4dfb460a153dbafb2b9b12b360c8757cec22cd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.41e-04 | 196 | 34 | 3 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.41e-04 | 196 | 34 | 3 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 196 | 34 | 3 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-04 | 197 | 34 | 3 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 4.48e-04 | 197 | 34 | 3 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-04 | 197 | 34 | 3 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-04 | 197 | 34 | 3 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 4.48e-04 | 197 | 34 | 3 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 197 | 34 | 3 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.54e-04 | 198 | 34 | 3 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 198 | 34 | 3 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 198 | 34 | 3 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 198 | 34 | 3 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 198 | 34 | 3 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-04 | 198 | 34 | 3 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.54e-04 | 198 | 34 | 3 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | MS-IIF-Others-HSPC|IIF / Disease, condition lineage and cell class | 4.61e-04 | 199 | 34 | 3 | 3384db80f6024bcabe2625f24d5f4e0d3d8caa7e | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.61e-04 | 199 | 34 | 3 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.68e-04 | 200 | 34 | 3 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.68e-04 | 200 | 34 | 3 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.68e-04 | 200 | 34 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.68e-04 | 200 | 34 | 3 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| Drug | HA1 100 | 3.96e-09 | 90 | 34 | 6 | CID003064778 | |
| Drug | AH6809 | 5.91e-07 | 45 | 34 | 4 | CID000119461 | |
| Drug | cBiMPS | 1.10e-06 | 14 | 34 | 3 | CID005487206 | |
| Drug | Rockout | 2.16e-06 | 2 | 34 | 2 | CID000644354 | |
| Drug | 3,3-dimethylacryloyl chloride | 2.16e-06 | 2 | 34 | 2 | CID000102394 | |
| Drug | sodium nitroprusside | 2.20e-06 | 261 | 34 | 6 | CID000045469 | |
| Drug | sulprostone | 3.75e-06 | 71 | 34 | 4 | CID005312153 | |
| Drug | alpha-ketoisovalerate | 9.25e-06 | 89 | 34 | 4 | CID000000049 | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A | 1.02e-05 | 196 | 34 | 5 | 2393_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.07e-05 | 198 | 34 | 5 | 6777_UP | |
| Drug | Benzyl N-[(1S)-1-[[(3S)-5-methyl-1,2-dioxo-hexan-3-yl]carbamoyl]-2-phenyl-ethyl]carbamate | 1.30e-05 | 4 | 34 | 2 | CID010365033 | |
| Drug | diguanosine pentaphosphate | 1.30e-05 | 4 | 34 | 2 | CID004577574 | |
| Drug | AC1NSKHR | 1.76e-05 | 34 | 34 | 3 | CID005311362 | |
| Drug | Diclofenac | 1.78e-05 | 570 | 34 | 7 | ctd:D004008 | |
| Drug | tetrahydrooxazine | 2.16e-05 | 5 | 34 | 2 | CID000449101 | |
| Drug | tyrphostin 23 | 2.64e-05 | 116 | 34 | 4 | CID000002052 | |
| Drug | nifedipine | 3.09e-05 | 415 | 34 | 6 | CID000004485 | |
| Drug | brazilein | 3.23e-05 | 6 | 34 | 2 | CID006453902 | |
| Drug | levormeloxifene | 3.23e-05 | 6 | 34 | 2 | ctd:C108255 | |
| Drug | AC1L1CTF | 3.23e-05 | 6 | 34 | 2 | CID000002056 | |
| Drug | 6-BME | 4.52e-05 | 7 | 34 | 2 | CID005748218 | |
| Drug | AC1L2VEC | 4.52e-05 | 7 | 34 | 2 | CID000129320 | |
| Drug | NSC618487 | 5.42e-05 | 933 | 34 | 8 | CID000005279 | |
| Drug | glutamin | 5.54e-05 | 461 | 34 | 6 | CID000000738 | |
| Drug | gaillardin | 6.03e-05 | 8 | 34 | 2 | CID000267247 | |
| Drug | GGTI-297 | 6.03e-05 | 8 | 34 | 2 | CID009956145 | |
| Drug | heptenoic acid | 6.03e-05 | 8 | 34 | 2 | CID000029373 | |
| Drug | N-palmitoyl-serine | 6.03e-05 | 8 | 34 | 2 | CID000085997 | |
| Drug | oxethazaine | 6.03e-05 | 8 | 34 | 2 | CID000004621 | |
| Drug | SC-46275 | 6.03e-05 | 8 | 34 | 2 | CID005311427 | |
| Drug | Y-26763 | 6.03e-05 | 8 | 34 | 2 | CID000121878 | |
| Drug | 2c5o | 6.03e-05 | 284 | 34 | 5 | CID000447956 | |
| Drug | fasudil | 7.38e-05 | 151 | 34 | 4 | CID000003547 | |
| Drug | pristane | 7.58e-05 | 152 | 34 | 4 | CID000015979 | |
| Drug | P6Chol | 7.74e-05 | 9 | 34 | 2 | CID000126085 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 8.84e-05 | 308 | 34 | 5 | CID000001915 | |
| Drug | dihydrochloride | 9.02e-05 | 159 | 34 | 4 | CID000070978 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.12e-04 | 168 | 34 | 4 | 3868_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.14e-04 | 169 | 34 | 4 | 6064_DN | |
| Drug | MCI-154 | 1.18e-04 | 11 | 34 | 2 | CID000123941 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.19e-04 | 171 | 34 | 4 | 7535_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.25e-04 | 173 | 34 | 4 | 5950_DN | |
| Drug | oxanol | 1.42e-04 | 12 | 34 | 2 | CID000136505 | |
| Drug | DMEP | 1.42e-04 | 12 | 34 | 2 | CID000008344 | |
| Drug | OD-q | 1.42e-04 | 179 | 34 | 4 | CID000001456 | |
| Drug | GF109203X | 1.43e-04 | 341 | 34 | 5 | CID000002396 | |
| Drug | Haloperidol | 1.44e-04 | 342 | 34 | 5 | ctd:D006220 | |
| Drug | AC1L1DW2 | 1.65e-04 | 186 | 34 | 4 | CID000002532 | |
| Drug | NSC611747 | 1.65e-04 | 352 | 34 | 5 | CID000002534 | |
| Drug | 2-MeSAMP | 1.67e-04 | 13 | 34 | 2 | CID000189762 | |
| Drug | LFA703 | 1.67e-04 | 13 | 34 | 2 | CID000449169 | |
| Drug | eckol | 1.67e-04 | 13 | 34 | 2 | ctd:C060311 | |
| Drug | KT5720 | 1.76e-04 | 189 | 34 | 4 | CID000003844 | |
| Drug | chelerythrine | 1.76e-04 | 357 | 34 | 5 | CID000002703 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.90e-04 | 193 | 34 | 4 | 2721_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 34 | 4 | 4828_UP | |
| Drug | B-43 | 1.95e-04 | 14 | 34 | 2 | CID006603792 | |
| Drug | AC1L1JG6 | 1.95e-04 | 14 | 34 | 2 | CID000005026 | |
| Drug | 8-N3cAMP | 1.95e-04 | 14 | 34 | 2 | CID006426627 | |
| Drug | 8-(6-aminohexyl)amino cyclic AMP | 1.95e-04 | 14 | 34 | 2 | CID000161999 | |
| Drug | AC1N7NQV | 1.95e-04 | 14 | 34 | 2 | CID004330476 | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; HL60; HG-U133A | 1.98e-04 | 195 | 34 | 4 | 1726_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 2283_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 6098_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 1508_UP | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A | 2.02e-04 | 196 | 34 | 4 | 1967_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 1326_UP | |
| Drug | Y-27632; Down 200; 3uM; MCF7; HT_HG-U133A_EA | 2.02e-04 | 196 | 34 | 4 | 832_DN | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 6014_DN | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 5685_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 1470_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5533_DN | |
| Drug | C070379 | 2.14e-04 | 199 | 34 | 4 | CID003034747 | |
| Drug | Bemegride [64-65-3]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 5014_DN | |
| Drug | butaprost | 2.14e-04 | 78 | 34 | 3 | CID005311035 | |
| Drug | PD150606 | 2.25e-04 | 15 | 34 | 2 | CID009839500 | |
| Drug | NA-382 | 2.25e-04 | 15 | 34 | 2 | CID000132534 | |
| Drug | NSC-114340 | 2.56e-04 | 16 | 34 | 2 | CID000004598 | |
| Drug | un-3 | 2.56e-04 | 16 | 34 | 2 | CID005327154 | |
| Drug | Clozapine | 2.66e-04 | 390 | 34 | 5 | ctd:D003024 | |
| Drug | norsolorinic acid | 2.90e-04 | 17 | 34 | 2 | CID000025102 | |
| Drug | GR 55562 | 3.26e-04 | 18 | 34 | 2 | CID000128017 | |
| Drug | PC-PI | 3.26e-04 | 18 | 34 | 2 | CID000007693 | |
| Drug | 8-azido cyclic AMP | 3.26e-04 | 18 | 34 | 2 | CID000115296 | |
| Drug | RS 102221 | 3.26e-04 | 18 | 34 | 2 | CID003693566 | |
| Drug | AC1L1CLB | 3.49e-04 | 92 | 34 | 3 | CID000001951 | |
| Drug | 8-thiomethyl-cAMP | 3.64e-04 | 19 | 34 | 2 | CID000093140 | |
| Drug | 8-azidoadenosine | 3.64e-04 | 19 | 34 | 2 | CID000160751 | |
| Drug | Sodium Fluoride | 3.87e-04 | 933 | 34 | 7 | ctd:D012969 | |
| Drug | NSC23766 | 4.20e-04 | 98 | 34 | 3 | CID000409805 | |
| Drug | calphostin C | 4.20e-04 | 431 | 34 | 5 | CID000002533 | |
| Drug | A3846_sigma | 4.47e-04 | 21 | 34 | 2 | CID005311238 | |
| Drug | (3Z)-3-[3-(hydroxyamino)indolin-2-ylidene]oxindole | 4.47e-04 | 21 | 34 | 2 | CID016073041 | |
| Drug | JTE-013 | 4.47e-04 | 21 | 34 | 2 | CID010223146 | |
| Drug | 4 alpha-phorbol | 4.86e-04 | 103 | 34 | 3 | CID000028683 | |
| Drug | AC1LA1RA | 4.91e-04 | 22 | 34 | 2 | CID000479966 | |
| Drug | Sp-8-Cl-cAMPS | 4.91e-04 | 22 | 34 | 2 | CID000133987 | |
| Drug | Ro 31-8830 | 5.00e-04 | 104 | 34 | 3 | CID000005084 | |
| Drug | PDBu | 5.00e-04 | 249 | 34 | 4 | CID000037783 | |
| Drug | W7 hydrochloride | 5.08e-04 | 250 | 34 | 4 | CID000005681 | |
| Disease | fibrolamellar carcinoma (is_implicated_in) | 1.21e-06 | 2 | 33 | 2 | DOID:5015 (is_implicated_in) | |
| Disease | neuromuscular disease (implicated_via_orthology) | 7.27e-06 | 4 | 33 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | Adrenal Cortical Adenoma | 7.27e-06 | 4 | 33 | 2 | C0206667 | |
| Disease | neonatal systemic lupus erythematosus | 4.35e-05 | 9 | 33 | 2 | EFO_0004537 | |
| Disease | Adrenal Cancer | 6.63e-05 | 11 | 33 | 2 | C0750887 | |
| Disease | Adrenal Gland Neoplasms | 6.63e-05 | 11 | 33 | 2 | C0001624 | |
| Disease | glycerophosphorylcholine measurement | 6.63e-05 | 11 | 33 | 2 | EFO_0020018 | |
| Disease | Abnormality of refraction | 9.02e-05 | 673 | 33 | 6 | HP_0000539 | |
| Disease | Neurodevelopmental Disorders | 1.54e-04 | 93 | 33 | 3 | C1535926 | |
| Disease | syndrome (implicated_via_orthology) | 1.84e-04 | 18 | 33 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | brain ischemia (biomarker_via_orthology) | 2.03e-04 | 102 | 33 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Left Ventricle Remodeling | 2.51e-04 | 21 | 33 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 2.51e-04 | 21 | 33 | 2 | C0600519 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.30e-04 | 24 | 33 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.30e-04 | 24 | 33 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 3.88e-04 | 26 | 33 | 2 | C0206698 | |
| Disease | bipolar disorder (is_implicated_in) | 4.83e-04 | 29 | 33 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | brain infarction (biomarker_via_orthology) | 6.27e-04 | 33 | 33 | 2 | DOID:3454 (biomarker_via_orthology) | |
| Disease | Influenza | 1.55e-03 | 52 | 33 | 2 | C0021400 | |
| Disease | carcinoma (implicated_via_orthology) | 2.34e-03 | 64 | 33 | 2 | DOID:305 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMNYGSYMEEKHMPP | 101 | P11308 | |
| TMDAFMLGMGMLGYP | 206 | Q96DH6 | |
| VVGAMTVGMGYSMYR | 71 | Q9Y241 | |
| MMYTAPGHHGYMNTG | 2046 | Q8WYB5 | |
| SGGYGQDALGMDPMM | 721 | P35222 | |
| NLYMVMEYVPGGEMF | 116 | P17612 | |
| MYAVYGALAVMGTMG | 101 | Q9HCP6 | |
| MAGAVPGAIMDEDYY | 1 | Q8IXH7 | |
| LYFVMDYIPGGDMMS | 741 | Q9NRM7 | |
| YGGMDGVGVPASMYG | 11 | O14770 | |
| MVVGMYYGAGLFMCI | 246 | Q8NG81 | |
| PEYGMFMYPEMGSCM | 731 | Q8IVU3 | |
| YMAMGFPGYDLSADD | 171 | Q9P215 | |
| GMMSIFLMGCYDPGS | 706 | P49916 | |
| RVMPYGMDAFMLGIG | 201 | O43347 | |
| GMDAFMLGIGMLGYP | 206 | O43347 | |
| EMIQPEYGMFMYPEG | 736 | Q9UII4 | |
| EYGMFMYPEGASCMW | 741 | Q9UII4 | |
| NLYMVMEYVPGGEMF | 116 | P22694 | |
| DMMYGGMRGMKGLVY | 66 | O75390 | |
| MDYAIMTGGDVAPMG | 196 | Q5T2N8 | |
| MAGVMGAYLGSPIYM | 111 | Q3KQZ1 | |
| RYGIGYLMADIMPDM | 711 | Q9H2J7 | |
| GQAIVYVMTGMYGDP | 126 | Q9H9S3 | |
| YVMTGMYGDPAEMGA | 131 | Q9H9S3 | |
| VLYGGDDAQGMMAAM | 186 | Q5U5Q3 | |
| MDYAIMTGGDVAPMG | 371 | Q5T9A4 | |
| GYLYGFVLGMGLMMV | 186 | Q6YI46 | |
| GYMAGMAAMPQTVYG | 361 | Q8WU79 | |
| YVMTGMYGDPSEMGA | 131 | P61619 | |
| SSMMPGYRHVYLEGM | 856 | O75038 | |
| GYADLEYAMMVSMGA | 156 | Q2M296 | |
| ASGMGGEMYPHGLEM | 251 | Q5T1R4 | |
| DDRYLYMVMEYMPGG | 161 | O75116 | |
| MGLVEGYDSMGYEMS | 566 | Q13472 | |
| DRYLYMVMEYMPGGD | 146 | Q13464 | |
| MDGSPYAHMFEMSAG | 1331 | Q13224 |